You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Selective Estrogen Receptor Modulator

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumor Trial in New York (RealRisks, BNAV)

Active, not recruiting
  • Breast Neoplasm
  • RealRisks
  • BNAV
  • New York, New York
    Columbia University Medical Center
Aug 16, 2022

Premenopausal Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Seoul (drug, diagnostic test, procedure)

Recruiting
  • Premenopausal Breast Cancer
  • Hormone Receptor-positive Breast Cancer
  • Tamoxifen Oral Product
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 14, 2022

Leiomyoma Trial run by the NICHD (CDB-2914)

Completed
  • Leiomyoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Laser-Induced Scar, Breast Cancer, Endometrial Cancer Trial in Herning (Vaginal laser treatment, sham, laser system)

Not yet recruiting
  • Laser-Induced Scar
  • +5 more
  • Vaginal laser treatment
  • +2 more
  • Herning, Denmark
    Gynecology Dept. Herning Hospital
Mar 15, 2022

Schizophrenia, Schizoaffective Disorder Trial in Melbourne (Raloxifene HCl, Placebo)

Completed
  • Schizophrenia
  • Schizoaffective Disorder
  • Raloxifene hydrochloride
  • Placebo
  • Melbourne, Victoria, Australia
    Monash Alfred Psychiatry Research Centre
Jan 6, 2020

Cachexia Trial in Germany, United Kingdom, United States (GSK2881078, Matching Placebo)

Completed
Has Results
  • Cachexia
  • Torrance, California
  • +10 more
Jun 24, 2020

Schizophrenia Trial in Shanghai (Raloxifene Hydrochloride, Placebo)

Completed
  • Schizophrenia
  • Raloxifene Hydrochloride
  • Placebo
  • Shanghai, Minhang, China
    CHINA
Sep 4, 2019

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Birmingham, Detroit, Columbus

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +2 more
  • Birmingham, Alabama
  • +3 more
Mar 2, 2021

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Melbourne (Raloxifene Hydrochloride, Placebo)

Unknown status
  • Schizophrenia
  • +2 more
  • Raloxifene Hydrochloride
  • Placebo
  • Melbourne, Victoria, Australia
    Alfred Hospital
Jan 6, 2020

Pancreas Cancer Trial in Fribourg (Bazedoxifene 20 mg)

Recruiting
  • Pancreas Cancer
  • Bazedoxifene 20 mg
  • Fribourg, Switzerland
    HFR Fribourg - cantonal hospital
Feb 9, 2022

Advanced Malignant Tumor Trial in Guangzhou, Zhengzhou, Nanjing (TQB3915 tablets)

Recruiting
  • Advanced Malignant Tumor
  • TQB3915 tablets
  • Guangzhou, Guangdong, China
  • +2 more
Jun 9, 2022

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ Trial in

Recruiting
  • Atypical Hyperplasia of the Breast
  • +2 more
  • Cancer Educational Materials
  • +3 more
  • Costa Mesa, California
  • +48 more
Jan 9, 2023

Missed Abortion, Anembryonic Pregnancy, Non-Viable Pregnancy Trial in Chapel Hill, Hillsborough (Ulipristal Acetate Tablets,

Recruiting
  • Missed Abortion
  • +2 more
  • Ulipristal Acetate Tablets
  • Misoprostol Pill
  • Chapel Hill, North Carolina
  • +3 more
Jun 9, 2022

Breast Cancer Trial in Poland, United States (ZN-c5, Abemaciclib)

Recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +6 more
Feb 14, 2022

Real-World Evidence In Patients Treated With Palbociclib

Recruiting
  • Metastatic Breast Cancer
  • Timisoara, Timiș, Romania
  • +5 more
Dec 7, 2022

Urogenital Abnormalities Trial (CDB-2914)

Withdrawn
  • Urogenital Abnormalities
  • (no location specified)
Dec 14, 2019

Infertility Trial (Letrozole, Clomiphine Citrate)

Unknown status
  • Infertility
  • (no location specified)
Jan 18, 2021

Resistance in ER+ Breast Cancer Patients:Translational Project

Recruiting
  • Breast Cancer
    • Aviano, Pordenone, Italy
    • +1 more
    Nov 8, 2023

    Metastatic Breast Cancer Trial in East Melbourne (BYl719)

    Completed
    • Metastatic Breast Cancer
    • East Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Aug 11, 2022

    Breast Cancer Trial in Shanghai (SCR-6852, Palbociclib)

    Recruiting
    • Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    May 18, 2022

    Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Tumor Trial in Worldwide (G1T48, Palbociclib)

    Completed
    • Carcinoma, Ductal, Breast
    • +6 more
    • Beverly Hills, California
    • +14 more
    Dec 14, 2022

    Metastatic ER+ Breast Cancer Trial in United States (TTC-352)

    Completed
    • Metastatic ER+ Breast Cancer
    • Scottsdale, Arizona
    • +3 more
    Aug 8, 2020

    Metastatic Breast Cancer Trial in Belgium, Netherlands (RAD1901)

    Completed
    • Metastatic Breast Cancer
    • Bruxelles, Belgium
    • +4 more
    Aug 16, 2022